CN104784489B - 一种治疗慢性宫颈炎合并hpv感染的中药制剂 - Google Patents
一种治疗慢性宫颈炎合并hpv感染的中药制剂 Download PDFInfo
- Publication number
- CN104784489B CN104784489B CN201510208667.5A CN201510208667A CN104784489B CN 104784489 B CN104784489 B CN 104784489B CN 201510208667 A CN201510208667 A CN 201510208667A CN 104784489 B CN104784489 B CN 104784489B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- chinese medicine
- medicine preparation
- caulis spatholobi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 44
- 206010008323 cervicitis Diseases 0.000 title claims abstract description 22
- 201000003988 chronic cervicitis Diseases 0.000 title claims abstract description 21
- 208000009608 Papillomavirus Infections Diseases 0.000 title claims abstract description 17
- 238000011282 treatment Methods 0.000 title description 35
- 241001250596 Pleione Species 0.000 claims abstract description 22
- 239000009636 Huang Qi Substances 0.000 claims abstract description 21
- 235000002848 Cyperus flabelliformis Nutrition 0.000 claims abstract description 18
- 235000014968 Peltiphyllum peltatum Nutrition 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 244000118872 Cyperus flabelliformis Species 0.000 claims abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 49
- 239000000284 extract Substances 0.000 claims description 16
- 239000012567 medical material Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 11
- 239000002775 capsule Substances 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 239000013049 sediment Substances 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000009472 formulation Methods 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 21
- 210000004369 blood Anatomy 0.000 abstract description 21
- 201000010099 disease Diseases 0.000 abstract description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 17
- 238000009825 accumulation Methods 0.000 abstract description 3
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 230000008506 pathogenesis Effects 0.000 abstract description 2
- 208000022361 Human papillomavirus infectious disease Diseases 0.000 abstract 1
- 244000104677 Peltiphyllum peltatum Species 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 13
- 231100000614 poison Toxicity 0.000 description 12
- 229940079593 drug Drugs 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 210000004291 uterus Anatomy 0.000 description 11
- 239000003440 toxic substance Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 241000701806 Human papillomavirus Species 0.000 description 7
- 238000002791 soaking Methods 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 244000025254 Cannabis sativa Species 0.000 description 6
- 241000233805 Phoenix Species 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 240000008042 Zea mays Species 0.000 description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 235000005822 corn Nutrition 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 230000003628 erosive effect Effects 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000003821 menstrual periods Effects 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- 210000003679 cervix uteri Anatomy 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 230000002980 postoperative effect Effects 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 206010048245 Yellow skin Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 125000000017 cortisol group Chemical group 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000003512 furunculosis Diseases 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 210000002445 nipple Anatomy 0.000 description 2
- 229940126701 oral medication Drugs 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 206010003693 Atrophic vulvovaginitis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010008254 Cervical cyst Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010064147 Gastrointestinal inflammation Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010034649 Peritoneal abscess Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000196245 Ulva intestinalis Species 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000010442 acute cervicitis Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 201000003505 cervical polyp Diseases 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 229940068682 chewable tablet Drugs 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 208000016369 nabothian cyst Diseases 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 201000010808 postmenopausal atrophic vaginitis Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000004441 taeniasis Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229940126702 topical medication Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510208667.5A CN104784489B (zh) | 2015-04-28 | 2015-04-28 | 一种治疗慢性宫颈炎合并hpv感染的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510208667.5A CN104784489B (zh) | 2015-04-28 | 2015-04-28 | 一种治疗慢性宫颈炎合并hpv感染的中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104784489A CN104784489A (zh) | 2015-07-22 |
CN104784489B true CN104784489B (zh) | 2016-10-05 |
Family
ID=53549980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510208667.5A Active CN104784489B (zh) | 2015-04-28 | 2015-04-28 | 一种治疗慢性宫颈炎合并hpv感染的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104784489B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111588780A (zh) * | 2020-07-09 | 2020-08-28 | 广西妙韵圆生药业有限公司 | 一种用于治疗宫颈hpv病毒感染的中药组合物及其制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105596581A (zh) * | 2016-02-01 | 2016-05-25 | 孙爱华 | 一种用于治疗人乳头瘤病毒感染的药物制剂及其制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101254267A (zh) * | 2007-11-13 | 2008-09-03 | 蒋坤元 | 一种治疗宫颈炎、子宫肥大等器质性病变的药物 |
-
2015
- 2015-04-28 CN CN201510208667.5A patent/CN104784489B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101254267A (zh) * | 2007-11-13 | 2008-09-03 | 蒋坤元 | 一种治疗宫颈炎、子宫肥大等器质性病变的药物 |
Non-Patent Citations (1)
Title |
---|
逍遥散加减治疗慢性宫颈炎50例;高兴来;《中医杂志》;20061031;第47卷(第10期);792 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111588780A (zh) * | 2020-07-09 | 2020-08-28 | 广西妙韵圆生药业有限公司 | 一种用于治疗宫颈hpv病毒感染的中药组合物及其制备方法 |
CN111588780B (zh) * | 2020-07-09 | 2021-07-27 | 广西妙韵圆生药业有限公司 | 一种用于治疗宫颈hpv病毒感染的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104784489A (zh) | 2015-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100586468C (zh) | 一种治疗乙肝的中药 | |
CN106267120A (zh) | 一种治疗鼻炎的中药制剂及其制备方法 | |
CN1895434B (zh) | 一种治疗子宫肌瘤的药物 | |
CN105343724A (zh) | 一种治疗妇科疾病的中药组合物 | |
CN104784489B (zh) | 一种治疗慢性宫颈炎合并hpv感染的中药制剂 | |
CN104173856A (zh) | 一种治疗带下症的中药组合物 | |
CN103007093A (zh) | 一种治疗妇科炎症的药物及其制备方法 | |
CN103908511B (zh) | 一种治疗软骨瘤的中药药丸及制备方法 | |
CN100556447C (zh) | 用于治疗银屑病的祛风止痒胶囊及其制备方法 | |
CN100431597C (zh) | 一种治疗慢性盆腔炎的中药制剂 | |
CN100371016C (zh) | 采取分期治疗乳腺病的中药制剂 | |
CN104887950A (zh) | 一种治疗乳痈的中药组合物 | |
CN104606661A (zh) | 一种治疗剖宫产后缺乳的中药催乳剂及其制备方法 | |
CN103656460A (zh) | 一种治疗糖尿病的中药组合物 | |
CN103550330B (zh) | 一种治疗子宫肌瘤的中药药剂 | |
CN102847123B (zh) | 一种治疗慢性盆腔炎的药物及其制备方法 | |
CN106256371A (zh) | 一种治疗血瘀型癥瘕的中药组合物及其制备方法 | |
CN105770772A (zh) | 一种治疗病毒性肝炎的中药组合物 | |
CN104906449A (zh) | 一种治疗子宫颈炎的中药 | |
CN104758627B (zh) | 一种治疗未产型慢性宫颈炎的中药制剂 | |
CN105412695A (zh) | 用于治疗牛子宫内膜炎的药物及其制备方法 | |
CN105267895A (zh) | 用于治疗牛产后血瘀型胞衣不下的药物及其制备方法 | |
CN105147963A (zh) | 一种治疗烧伤后急性肾功能衰竭的中药 | |
CN105168746B (zh) | 一种治疗小儿蛲虫病的护理用药物及其制备方法 | |
CN103845719A (zh) | 一种产后康复的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Gao Ying Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160420 Address after: 277700 Shandong province Linyi Lanling County Guanta Road No. 12, building 1, unit 3, room 101 Applicant after: Gao Ying Address before: 1 residential building, No. 443 Changjiang East Road, Huangdao District, Shandong, China, 1708, China, 266520 Applicant before: Chen Da bio tech ltd, Qingdao |
|
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Gao Ying Inventor after: Li Yishu Inventor after: Chen Hong Inventor before: Gao Ying |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160908 Address after: Qingdao City, Shandong province 266000 flood ditch cleaning village 106 2 Applicant after: Chen Hong Applicant after: Gao Ying Address before: 277700 Shandong province Linyi Lanling County Guanta Road No. 12, building 1, unit 3, room 101 Applicant before: Gao Ying |
|
CP02 | Change in the address of a patent holder |
Address after: 223100 Hongze District Electronic Commerce Industrial Park in Huaian, Jiangsu Co-patentee after: Gao Ying Patentee after: Chen Hong Address before: Qingdao City, Shandong province 266000 flood ditch cleaning village 106 2 Co-patentee before: Gao Ying Patentee before: Chen Hong |
|
CP02 | Change in the address of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181112 Address after: 401147 Yangtze River Business District, No. 5 Longshan Road, Longshan Street, Yubei District, Chongqing City, 4 buildings 14-13 Patentee after: Chongqing Century Brand Planning Consulting Co., Ltd. Address before: 223100 Electronic Commerce Industrial Park, Hongze District, Huaian, Jiangsu Co-patentee before: Gao Ying Patentee before: Chen Hong |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200311 Address after: 610000 Longjing North Street, Wuhou District cluster bridge street, Chengdu, Sichuan, 190 Patentee after: Sichuan life source Health Management Co., Ltd. Address before: 401147 Yangtze River Business District, No. 5 Longshan Road, Longshan Street, Yubei District, Chongqing City, 4 buildings 14-13 Patentee before: Chongqing Century Brand Planning Consulting Co., Ltd. |